MARKET

NYMX

NYMX

Nymox
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.340
+0.160
+7.34%
Closed 16:00 03/31 EDT
OPEN
2.170
PREV CLOSE
2.180
HIGH
2.430
LOW
2.170
VOLUME
85.95K
TURNOVER
--
52 WEEK HIGH
4.090
52 WEEK LOW
1.320
MARKET CAP
163.73M
P/E (TTM)
-11.9571
1D
5D
1M
3M
1Y
5Y

NYMX News

More
  • Is Nymox Pharmaceutical (NASDAQ:NYMX) In A Good Position To Deliver On Growth Plans?
  • Simply Wall St. · 03/21 15:10
  • Nymox Pharma Highlights New Peer Review Publication Of Its Prostate Cancer Candidate Fexapotide In World Journal Of Urology
  • Benzinga · 02/24 14:31
  • Nymox Announces New Peer Review Publication of Prostate Cancer Fexapotide Clinical Trial Results in World Journal of Urology
  • GlobeNewswire · 02/24 14:30
  • Nymox Pharmaceutical: Employee Resume Substantiates Concerns
  • Seeking Alpha - Article · 02/20 16:00

Industry

Biotechnology & Medical Research
-0.49%
Pharmaceuticals & Medical Research
-0.25%

Hot Stocks

Symbol
Price
%Change

About NYMX

Nymox Pharmaceutical Corp is a Canada-based biopharmaceutical company. The Company is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of low-grade localized prostate cancer. The Company operates through the research and development of products for the aging population segment. The Company markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. The Company also owns rights for its marketed products, its investigational drug, as well as other therapeutic and diagnostic indications. The Company also has the rights for the use of statin drugs for the treatment and prevention of Alzheimer's disease. The Company's subsidiaries include Nymox Corporation and Serex, Inc. Nymox Corporation conducts research and development, while Serex, Inc. conducts research and development, and manufacturing of NicAlert and TobacAlert.
More

Webull offers kinds of Nymox Pharmaceutical Corp stock information, including NASDAQ:NYMX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NYMX stock news, and many more online research tools to help you make informed decisions.